On Tuesday, July 9th, Dr. Daniel Fierer of the Icahn School of Medicine at Mount Sinai presented on: “Treat Now or Wait? Acute HCV Infection”
1. Explain the epidemiology of the hepatitis C virus (HCV).
2. Discuss laboratory testing and diagnosis of HCV infection.
3. Design a therapeutic regimen and monitoring plan for the treatment of HCV.
Dr. Fierer received his medical degree from Yale University and his Infectious Diseases training at the National Institutes of Health. In 2006, he and his colleagues at Mount Sinai recognized the presence of an epidemic of hepatitis C infection among HIV-infected men-who-have-sex-with-men in New York City. Since that time, Dr. Fierer has become a leader in the investigation of this emerging epidemic in the US and worldwide. His work in the field has included characterizing the rapid onset of liver fibrosis in these men, the behaviors, molecular epidemiology, and body fluids associated with sexual transmission of HCV, and pioneering the use of direct-acting antivirals in the treatment of early HCV infection. His group’s work has been presented at national and international conferences and published in multiple peer-reviewed journals.